Cognition Therapeutics Inc

NASDAQ:CGTX   3:59:51 PM EDT
2.60
+0.11 (+4.42%)
Earnings Announcements

Cognition Therapeutics Reports First Quarter 2022 Financial Results And Provides Business Update

Published: 05/11/2022 11:18 GMT
Cognition Therapeutics Inc (CGTX) - Cognition Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update.
Q1 Loss per Share $0.17.
Estimates That It Has Sufficient Cash to Fund Operations and Capital Expenditures Into Second Half of 2023.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.29

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.35

More details on our Analysts Page.